Bortezomib Market, By Product Type, By Application, By End User, By Geography

PUBLISHED: February 27, 2025

PAGES: 140 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Global Bortezomib Market is estimated to be valued at USD 25.7 Mn in 2025 and is expected to reach USD 35.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 25.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.60%	2032 Value Projection:	USD 35.2 Mn

Figure. Bortezomib Market Share (%), By Region 2025

Bortezomib, commonly known as Velcade, is a proteasome inhibitor that acts as a targeted cancer therapy. It has proven to be an effective treatment option for multiple myeloma and other cancers. Increasing prevalence of cancer worldwide along with growing geriatric population susceptible to myeloma can boost demand for Bortezomib. Drug being designated with orphan drug status has encouraged manufacturers to invest in this market. However, patent expiry of the drug can hamper the market growth. Promising therapeutic efficacy and expanding applications of Bortezomib can offer lucrative opportunities for the global bortezomib market growth in the near future.

Market Dynamics:

Global bortezomib market growth is driven by rising cancer burden globally. The market growth can be attributed to increasing incidence rates of multiple myeloma, approval for additional indications, and expanding geriatric population base who are more prone to developing myeloma. As per the National Cancer Institute, more than 150,000 cases of multiple myeloma were reported in the US in 2020. High treatment and R&D costs associated with Bortezomib can hamper the market growth. Patent expiry of innovative drug between 2015 to 2020 has encouraged production of generic versions, and this can negatively impact the sales of branded Velcade. However, ongoing trials evaluating the potential of Bortezomib in other disease indications can present new opportunities.

Key features of the study:

This report provides in-depth analysis of the global bortezomib market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global bortezomib market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson, Takeda Pharmaceutical Company Ltd, Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Ltd, and Scion Pharma LLC

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global bortezomib market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bortezomib market

Detailed Segmentation-

By Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Injection
- Powder for Injection
By Application Insights (Revenue, USD Mn, 2020 - 2032)
- Multiple Myeloma
- Mantle Cell Lymphoma
- Other Hematological Malignancies
By End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals
- Oncology Clinics
- Ambulatory Surgical Centers
- Others (Research Institutes, Cancer Centers)
By Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Hikma Pharmaceuticals
- Pfizer
- Meitheal Pharmaceuticals
- Novartis International AG
- Bristol Myers Squibb
- NATCO Pharma
- Teva Pharmaceuticals
- Reddy's Laboratories
- Gland Pharma
- Shilpa Medicare
- Qilu Pharmaceutical
- Scion Pharmaceuticals
- Farmhispania Group
- Coresyn
- Chem-Stone (Guangzhou)
- Hubei Honch Pharmaceutical
- Vinkem Labs
- Icrom
- TAPI Teva
- Chengdu Aslee Biopharmaceuticals

Product Code: CMI7281

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Bortezomib Market, By Product Type
- Global Bortezomib Market, By Application
- Global Bortezomib Market, By End User
- Global Bortezomib Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Bortezomib Market, By Product Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Powder for Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Bortezomib Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Multiple Myeloma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mantle Cell Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Hematological Malignancies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Bortezomib Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Oncology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Research Institutes, Cancer Centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Bortezomib Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Mn)
- Market Y-o-Y Growth Analysis (%), 220 - 2032, (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country/Sub-region, 2020 - 2032, (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Meitheal Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis International AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NATCO Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gland Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Shilpa Medicare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qilu Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Scion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Farmhispania Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Coresyn
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Chem-Stone (Guangzhou)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hubei Honch Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vinkem Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Icrom
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
TAPI Teva
Chengdu Aslee Biopharmaceuticals